Praxis Precision Medicines (PRAX) EBT Growth (3y) (2022 - 2026)

Praxis Precision Medicines (PRAX) EBT Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 6.22%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.16%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 86.16%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 41.79%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 95.61%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -38.56%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 38.36%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 64.03%
10 Praxis Precision Medicines 10.24 Bn 9.48 Bn - -152.58%

Historic Data

Download Data
DateValue
Jun 30, 2026 -152.58%
Mar 31, 2026 -145.56%
Dec 31, 2025 -40.18%
Sep 30, 2025 -25.58%
Jun 30, 2025 -8.36%
Mar 31, 2025 3.08%
Dec 31, 2024 -68.89%
Sep 30, 2024 -15.14%
Jun 30, 2024 -2.56%
Mar 31, 2024 -27.01%
Dec 31, 2023 -100.86%
Sep 30, 2023 -16.65%
Jun 30, 2023 -44.66%
Mar 31, 2023 -65.72%
Dec 31, 2022 -190.97%
Sep 30, 2022 -60.61%